Media Coverage header image

Media Coverage

Advanced Search
  • 12032018
    EurekaAlert

    Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4. Their findings provide new insights into the progression of the disease from precursor conditions and suggest approaches for novel treatments. Testing will be performed at each participant's local Quest Diagnostics laboratory. To sign up for the study, please visit http://www.promisestudy.org.

  • 12032018
    BusinessWire

    Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data. Humana, MultiPlan, Quest Diagnostics and UnitedHealth Group’s (NYSE: UNH) Optum and UnitedHealthcare announced the launch of the Synaptic Health Alliance pilot project in April.

  • 12012018
    North Jersey Communications

    Quest Diagnostics made it official: It is coming to the city and bringing 1,100 jobs. The company told officials it hopes to break ground for the 250,000-square-foot facility and accompanying five to seven-story parking garage this spring, officials said.

  • 11292018
    Medical Health News

    Quest Diagnostics Inc. (Quest), an American diagnostic information service provider, has reportedly announced that it has inked an agreement to acquire the laboratory services business unit belonging to Boyce and Bynum Pathology Laboratories (BBPL), a clinical & diagnostic laboratory service provider.

  • 11282018
    ABC 17 News This Morning - KMIZ-TV

    Parts of Boyce and Bynum Pathology Labs are set to be acquired by Quest Diagnostics. Quest announced they recently signed an agreement to acquire the assets of Boyce and Bynum's clinical laboratory services.

  • 11282018
    360Dx

    Quest Diagnostics announced today that it will build a 250,000-square-foot flagship laboratory in Clifton, New Jersey. The new laboratory will become the largest of the more than 20 major laboratory facilities in the Quest network and will employ more than 1,100 people. It is expected to be operational in early 2021.

  • 11282018
    Wall Street Journal, The

    The questions sound familiar: “Describe a time when you went above and beyond;” “Tell me about a time when you had to deliver bad news to a customer.” But in this telephone job interview, there is a twist: No human is on the other end of the line. Major companies such as laboratory-test provider Quest Diagnostics Inc., hospital operator HCA Healthcare Inc. and insurer Allstate Insurance Co. use such interviews for some hiring, as do retailers, restaurant chains and law firms.

  • 11272018
    PR Newswire

    Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest.

  • 11212018
    360Dx

    A new mass spectrometry blood test from Quest Diagnostics aims to provide physicians with an easy tool for assessing insulin resistance as an early predictor of future diabetes. The test, called the Cardio IQ Insulin Resistance Panel with Score, has been offered for about two months through Quest and is performed at Quest's Nichols Institute in San Juan Capistrano, California.

  • 11192018
    STAT

    Jeffrey Gudin, M.D., is director of pain and palliative care at Englewood Hospital and Medical Center in New Jersey and a medical adviser for Quest Diagnostics. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT Act, is now the law of the land. This comprehensive, bipartisan bill, which aims to address the prolonged national opioid crisis, offers a rare opportunity to applaud progress in the national effort to address one of the great health care epidemics of our time: misuse of opioids and other prescription drugs. But there is still much more work to be done.

  • 11172018
    Marin Independent Journal

    The Marin Healthcare District has sold its four outpatient clinical laboratories where blood is drawn for tests to Quest Diagnostics, a publicly-traded company based in Secaucus, New Jersey. The acquisition will double the number of labs Quest operates in Marin to eight. The Marin Healthcare District labs sold are located at 100 A Drake’s Landing, Greenbrae; 5 Bon Air Road, Larkspur; 23 Reed Blvd., Mill Valley; and 75 Rowland Way, Novato. Terms of the sale were not disclosed.

  • 11172018
    Health IT Newsfeed

    Developing novel approaches to understand pre-disease and health is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice chair for Scientific Innovation in the department of Medicine at Brigham and Women's Hospital. n a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.

  • 11162018
    Becker's Hospital Review Online

    Quest Diagnostics now supports Apple's health records feature, making it the second clinical testing laboratory to join the project. Early in 2018, the iPhone maker released plans to integrate patient health records — including allergies, immunizations and lab results — into its Health app as part of the iOS 11.3 beta rollout.

  • 11152018
    360Dx

    Lab giants Quest Diagnostics and Laboratory Corporation of America both launched consumer-initiated testing services this month, empowering consumers to select laboratory testing kits to monitor their health. The new testing services — Pixel by LabCorp, introduced on Nov. 1, and QuestDirect, launched on Nov. 7 — reflect changing trends in how consumers access healthcare, according to company executives.

  • 11152018
    Outbreak News Today

    New data from the Centers for Disease Control and Prevention (CDC) show tickborne diseases are again on the rise. In 2017, state and local health departments reported a record number of cases of tickborne disease to CDC. Lyme disease in the US: The Quest Diagnostics Health Trends report

  • 11152018
    Bloomberg Businessweek

    Doctors, hospitals and medical labs used to be concerned about patients who didn’t have insurance not paying their bills. Now they’re scrambling to get paid by the ones who do have insurance. Even large medical companies with national operations are facing the problem. Quest Diagnostics Inc., the lab-testing giant, said 20 percent of services billed to patients in the third quarter of this year went unpaid, costing the company about $80 million in lost revenue.

  • 11112018
    New England Journal of Medicine Online

    It is unclear whether supplementation with vitamin D reduces the risk of cancer or cardiovascular disease, and data from randomized trials are limited. Blood samples were obtained at baseline during the run-in period from all willing participants — 16,956 of the 25,871 persons who underwent randomization (65.5%). At no cost to the trial, Quest Diagnostics donated and performed serum 25-hydroxyvitamin D assays with the use of liquid chromatography–tandem mass spectrometry on all samples that could be analyzed.

  • 11102018
    360Dx

    Clinical Genomics and Quest Diagnostics today announced a five-year extension to a US supply agreement for the InSure One fecal immunochemical test (FIT). Clinical Genomics manufacturers FIT tests, including InSure One FIT. Under the supply agreement extension, Quest will continue to provide the tests to physicians and organized provider groups across the US, including specialized programs to improve colorectal cancer screening rates for accountable care organizations and other organizations focused on value-based care models.

  • 11082018
    Quest Diagnostics

    In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.

  • 11082018
    ROI NJ

    Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory services business of England-based Oxford Immunotec Global PLC, the two companies announced Tuesday. Under terms of the deal, Secaucus-based Quest has purchased the business from Oxford, including the T-SPOT TB tuberculosis and Accutix tick disease testing services provided at labs in Tennessee and Massachusetts.

  • 11082018
    WRCB-TV Online

    Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that MyQuest, used by more than six million people to see, store and share their results and health information using a smartphone, tablet or desktop computer, now supports Health Records on iPhone. In addition, Quest recently launched a MyQuest update that provides new features such as direct access testing, the ability to add dependents or other approved users, real-time scheduling and more for patients as they become more engaged in managing their healthcare decisions.

  • 11082018
    360Dx

    Horizon Blue Cross Blue Shield of New Jersey today announced it has renewed its laboratory services relationship with Laboratory Corporation of America and added Quest Diagnostics as an in-network provider of such services.

  • 11082018
    NJ Biz

    Horizon Blue Cross Blue Shield of New Jersey will add Quest Diagnostics as an in-network provider of diagnostic information services for its 2.8 million members effective Jan. 1. Quest has more than 300 patient access points in New Jersey and will serve all Horizon members with the exception of managed Medicaid and Dual Eligible Special Needs plan beneficiaries.

  • 11072018
    FierceBiotech

    Quest Diagnostics launched a direct-to-consumer service that allows users to order and pay for lab tests from home. Dubbed QuestDirect, the online service offers 35 diagnostic test packages covering general health and wellness, men’s and women’s health, and the heart and digestive system, as well as panels for infections or sexually transmitted diseases.

  • 10302018
    Forbes

    Most of the time, finding a colon in a vacant house would be bad or even horrific news. But not in this case.[CR-LF][CR-LF]On October 20th I wrote for Forbes about someone stealing a 10-foot-long, 150-pound inflatable colon. This wasn't a colon from one of those huge floats in the Macy's Thanksgiving Parade, but a colon from the Colon Cancer Coalition meant to raise awareness for colon cancer screening as part of a campaign called “Get Your Rear in Gear.” Quest Diagnostics Health & Wellness and employees of Salix Pharmaceuticals also offered money to help purchase a replacement.

Show 5102550100 per page